Article: Effect in bronchial asthma of a new beta-adrenergic blocking drug atenolol (ICI 66, 082)

The bronchial effect of intravenous atenolol (ICI 66.082) has been studied in a double-blind cross over trial in 10 patients with pronounced, labile bronchial asthama. A single i.v. dose of atenolol 3 mg. sufficient to cause a fall in heart rate and systolic blood pressure at rest, induced only a slight and clincially almost negligible impairment of ventilatory function. An ordinary therapeutic dose of salbutamol by inhalation far outweighed the bronchial effect of atenolol. The drug appears promising with regard to its cardio-selective properties.

Citing Articles

Cardioselective beta-blocker use in patients with reversible airway disease.

Salpeter S, Ormiston T, Salpeter E Cochrane Database Syst Rev. 2001; (2):CD002992.

PMID: 11406056 PMC: 8689715. DOI: 10.1002/14651858.CD002992.

Influence of pindolol (Visken) on respiratory function in 20 asthmatic patients.

Christensen C, Boye N, ERIKSON H, Hansen G Eur J Clin Pharmacol. 1978; 13(1):9-12.

PMID: 346356 DOI: 10.1007/BF00606674.

Atenolol: a review of its pharmacological properties and therapeutic efficacy in angina pectoris and hypertension.

Heel R, Brogden R, Speight T, Avery G Drugs. 1979; 17(6):425-60.

PMID: 38096 DOI: 10.2165/00003495-197917060-00001.

References

1.

Hansson L, Aberg H, Karlberg B, Westerlund A . Controlled study of atenolol in treatment of hypertension. Br Med J. 1975; 2(5967):367-70. PMC: 1673197. DOI: 10.1136/bmj.2.5967.367. View

2.

Petrie J, Galloway D, Webster J, SIMPSON W, Lewis J . Atenolol and bendrofluazide in hypertension. Br Med J. 1975; 4(5989):133-5. PMC: 1674832. DOI: 10.1136/bmj.4.5989.133. View

3.

Jones R . Significance of effect of beta blockade on ventilatory function in normal and asthmatic subjects. Thorax. 1972; 27(5):572-6. PMC: 470552. DOI: 10.1136/thx.27.5.572. View

4.

Kumana C, Marlin G, Kaye C, Smith D . New approach to assessment of cardioselectivity of beta-blocking drugs. Br Med J. 1974; 4(5942):444-7. PMC: 1612509. DOI: 10.1136/bmj.4.5942.444. View

5.

AStrom H, Vallin H . Effect of a new beta-adrenergic blocking agent, ICI 66o82, on exercise haemodynamics and airway resistance in angina pectoris. Br Heart J. 1974; 36(12):1194-1200. PMC: 458942. DOI: 10.1136/hrt.36.12.1194. View

6.

AStrom H . Comparison of the effects on airway conductance of a new selective beta-adrenergic blocking drug, atenolol, and propranolol in asthmatic subjects. Scand J Respir Dis. 1975; 56(6):292-6. View

7.

Sowton E, Das Gupta D, Baker I . Comparative effects of beta adrenergic blocking drugs. Thorax. 1975; 30(1):9-18. PMC: 470238. DOI: 10.1136/thx.30.1.9. View

8.

Barrett A, Carter J, Fitzgerald J, Hull R, Le Count D . A new type of cardioselective adrenoceptive blocking drug. Br J Pharmacol. 1973; 48(2):340P. PMC: 1776195. View

9.

. Editorial: side effects of practolol. Br Med J. 1975; 2(5971):577-8. PMC: 1673478. View

10.

Roy P, Day L, Sowton E . Effect of new beta-adrenergic blocking agent, Atenolol (Tenormin), on pain frequency, trinitrin consumption, and exercise ability. Br Med J. 1975; 3(5977):195-7. PMC: 1674130. DOI: 10.1136/bmj.3.5977.195. View

11.

ADDIS G, Thorp J . Effects of oxprenolol on the airways of normal and bronchitic subjects. Eur J Clin Pharmacol. 1976; 9(4):259-63. DOI: 10.1007/BF00561658. View

12.

BEUMER H, Hardonk H . Side-effects of beta-adrenergic blocking drugs in asthmatics. Indian Heart J. 1972; 24:Suppl 1:226-30. View

Effect in Bronchial Asthma of a New Beta-adrenergic Blocking Drug Atenolol (ICI 66, 082)